Web Stats Provided By Google Analytics

Wednesday, June 19, 2013

New Nrti BMS-986001 Potently Suppresses HIV in Early Monotherapy Study

Antiretroviral therapy has improved dramatically since the advent of effective combination treatment, but there is still a need for new drugs for individuals who have developed drug resistance, cannot tolerate, or do not respond well to existing options.

http://www.hivandhepatitis.com/hiv-treatment/experimental-hiv-drugs/4146-new-nrti-bms-986001-potently-suppresses-hiv-in-early-monotherapy-study

No comments:

Post a Comment